The Ask the CEO conference is intended to provide the investment community with access to ask their questions directly to management. Investors and interested parties will have the opportunity to submit questions live during the event. Questions can also be pre-submitted leading up to the event through virtualinvestorco.com/asktheceo-xbio. Participating companies will answer as many questions as possible during the event.
A live video webcast of the event will be available on the Events page in the Investors section of the Company s website (xeneticbio.com). A webcast replay will be available two hours following the live presentation and will be accessible for 90 days.
About
The Company is also developing its personalized CAR T platform technology, XCART, to develop cell-based therapeutics targeting the unique B-Cell receptor on the surface of an individual patient s malignant tumor cells for the treatment of B-Cell lymphomas.
Contact:
Tel: (833) 475-8247}
Email: xbio@jtcir.com
(C) 2023 Electronic News Publishing, source